These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761 [TBL] [Abstract][Full Text] [Related]
3. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219 [TBL] [Abstract][Full Text] [Related]
4. Lorenzo's oil: advances in the treatment of neurometabolic disorders. Ferri R; Chance PF Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756 [No Abstract] [Full Text] [Related]
5. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Moser HW; Loes DJ; Melhem ER; Raymond GV; Bezman L; Cox CS; Lu SE Neuropediatrics; 2000 Oct; 31(5):227-39. PubMed ID: 11204280 [TBL] [Abstract][Full Text] [Related]
6. [A case of adolescent adrenoleukodystrophy with clinical improvement after allogeneic bone marrow transplantation (allo-BMT)]. Tsujii T; Kinoshita M; Tomimoto H; Hitomi T; Okazaki T; Uchiyama T; Shibasaki H Rinsho Shinkeigaku; 2004 Oct; 44(10):667-72. PubMed ID: 15568481 [TBL] [Abstract][Full Text] [Related]
7. [Endocrine disease in adrenoleukodystrophy]. Girard S; Bruckert E; Turpin G Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421 [TBL] [Abstract][Full Text] [Related]
9. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883 [TBL] [Abstract][Full Text] [Related]
10. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy]. Söderfeldt B Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039 [No Abstract] [Full Text] [Related]
11. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. Zinkham WH; Kickler T; Borel J; Moser HW N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677 [No Abstract] [Full Text] [Related]
12. Lorenzo's oil: a reassessment. Poulos A; Robertson EF Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809 [No Abstract] [Full Text] [Related]
13. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil. Tanaka M; Koike R; Kuwabara T Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141 [No Abstract] [Full Text] [Related]
14. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy. Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials. Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253 [No Abstract] [Full Text] [Related]
16. More on Lorenzo's oil. Odone A; Odone M N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741 [No Abstract] [Full Text] [Related]
17. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy. Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654 [TBL] [Abstract][Full Text] [Related]